Last Price
31.12
Today's Change
-0.08 (0.25%)
Day's Change
30.33 - 31.42
Trading Volume
753,116
Exchange: NASDAQ Global Market NASDAQ Global Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Mr. Thomas G. Frinzi Mr. Thomas G. Frinzi
Full Time Employees: 1,056 1,056
IPO Date: 1992-02-24 1992-02-24
CIK: 0000718937 0000718937
ISIN: US8523123052 US8523123052
CUSIP: 852312305 852312305
Beta: 0.59 0.59
Last Dividend: 0.00 0.00
Dcf Diff: -19.28 -19.28
Dcf: 50.40 50.40
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.